Marisa Miraldo

Names

Identifer

Contact

Affiliations

• Imperial College / Business School
  • EDIRC entry
  • location:

Research profile

author of:

• Identification of Peer Effects using Panel Data (RePEc:arx:papers:2108.11545)
  by Marisa Miraldo & Carol Propper & Christiern Rose
• Are You What You Eat? Healthy Behaviour and Risk Preferences (RePEc:bpj:bejeap:v:17:y:2017:i:1:p:25:n:1)
  by Galizzi Matteo M. & Miraldo Marisa
• The incentive effects of payment by results (RePEc:chy:respap:19cherp)
  by Marisa Miraldo & Maria Goddard & Peter C Smith
• Reference Pricing Versus Co-Payment in the Pharmaceutical Industry: Price, Quality and Market Coverage (RePEc:chy:respap:25cherp)
  by Marisa Miraldo
• Hospital Financing and the Development and Adoption of New Technologies (RePEc:chy:respap:26cherp)
  by Marisa Miraldo
• Reference Pricing Versus Co-Payment in the Pharmaceutical Industry: Firm's Pricing Strategies (RePEc:chy:respap:27cherp)
  by Marisa Miraldo
• Optimal Contracts and Contractual Arrangements Within the Hospital: Bargaining vs. Take-it-or-leave-it Offers (RePEc:chy:respap:37cherp)
  by Matteo M Galizzi & Marisa Miraldo
• Establishing a Fair Playing Field for Payment by Results (RePEc:chy:respap:39cherp)
  by Anne Mason & Marisa Miraldo & Luigi Siciliani & Peter Sivey & Andrew Street
• Price Adjustment in the Hospital Sector (RePEc:chy:respap:41cherp)
  by Marisa Miraldo & Luigi Siciliani & Andrew Street
• Price regulation of pluralistic markets subject to provider collusion (RePEc:chy:respap:45cherp)
  by Roberta Longo & Marisa Miraldo & Andrew Street
• Innovation Diffusion and Physician Networks: Keyhole Surgery for Cancer in the English NHS (RePEc:cpr:ceprdp:15515)
  by Propper, Carol & Barrenho, Eliana & Gautier, Eric & Miraldo, Marisa & Rose, Christiern
• Should prospective payments be differentiated for public and private healthcare providers? (RePEc:cup:hecopl:v:4:y:2009:i:04:p:383-403_00)
  by Mason, Anne & Street, Andrew & Miraldo, Marisa & Siciliani, Luigi
• Are English treatment centres treating less complex patients? (RePEc:eee:hepoli:v:94:y:2010:i:2:p:150-157)
  by Street, Andrew & Sivey, Peter & Mason, Anne & Miraldo, Marisa & Siciliani, Luigi
• Reference pricing and firms' pricing strategies (RePEc:eee:jhecon:v:28:y:2009:i:1:p:176-197)
  by Miraldo, Marisa
• Price adjustment in the hospital sector (RePEc:eee:jhecon:v:30:y:2011:i:1:p:112-125)
  by Miraldo, Marisa & Siciliani, Luigi & Street, Andrew
• The effects of hospitals' governance on optimal contracts: Bargaining vs. contracting (RePEc:eee:jhecon:v:30:y:2011:i:2:p:408-424)
  by Galizzi, Matteo M. & Miraldo, Marisa
• Doctor–patient differences in risk and time preferences: A field experiment (RePEc:eee:jhecon:v:50:y:2016:i:c:p:171-182)
  by Galizzi, Matteo M. & Miraldo, Marisa & Stavropoulou, Charitini & van der Pol, Marjon
• Physician altruism and moral hazard: (no) Evidence from Finnish national prescriptions data (RePEc:eee:jhecon:v:65:y:2019:i:c:p:153-169)
  by Crea, Giovanni & Galizzi, Matteo M. & Linnosmaa, Ismo & Miraldo, Marisa
• The impact of publicly subsidised health insurance on access, behavioural risk factors and disease management (RePEc:eee:socmed:v:217:y:2018:i:c:p:135-151)
  by Miraldo, Marisa & Propper, Carol & Williams, Rachael I.
• The importance of surgeons and their peers in adoption and diffusion of innovation: An observational study of laparoscopic colectomy adoption and diffusion in England (RePEc:eee:socmed:v:272:y:2021:i:c:s0277953621000472)
  by Barrenho, Eliana & Miraldo, Marisa & Propper, Carol & Walsh, Brendan
• The impact of the consumer and neighbourhood food environment on dietary intake and obesity-related outcomes: A systematic review of causal impact studies (RePEc:eee:socmed:v:299:y:2022:i:c:s027795362200185x)
  by Atanasova, Petya & Kusuma, Dian & Pineda, Elisa & Frost, Gary & Sassi, Franco & Miraldo, Marisa
• Inequities in cancer drug development in terms of unmet medical need (RePEc:eee:socmed:v:302:y:2022:i:c:s0277953622002593)
  by Barrenho, Eliana & Halmai, Réka & Miraldo, Marisa & Tzintzun, Iván & Raïs Ali, Setti & Toulemon, Léa & Dupont, Jean-Claude K. & Rochaix, Lise
• Impact of extreme temperatures on emergency hospital admissions by age and socio-economic deprivation in England (RePEc:eee:socmed:v:308:y:2022:i:c:s0277953622004993)
  by Rizmie, Dheeya & de Preux, Laure & Miraldo, Marisa & Atun, Rifat
• The role of patient organisations in research and development: Evidence from rare diseases (RePEc:eee:socmed:v:338:y:2023:i:c:s0277953623006895)
  by Gentilini, Arianna & Miraldo, Marisa
• Physician altruism and moral hazard: (no) evidence from Finnish national prescriptions data (RePEc:ehl:lserod:100301)
  by Crea, Giovanni & Galizzi, Matteo M. & Linnosmaa, Ismo & Miraldo, Marisa
• Bandwagoning, free-riding and heterogeneity in influenza vaccine decisions: an online experiment (RePEc:ehl:lserod:113487)
  by Galizzi, Matteo M. & W. Lau, Krystal & Miraldo, Marisa & Hauck, Katharina
• In sickness but not in wealth: field evidence on patients’ risk preferences in the financial and health domain (RePEc:ehl:lserod:64764)
  by Galizzi, Matteo M. & Miraldo, Marisa & Stavropoulou, Charitini
• Doctor–patient differences in risk and time preferences: a field experiment (RePEc:ehl:lserod:68143)
  by Galizzi, Matteo M. & Miraldo, Marisa & Stavropoulou, Charitini & van der Pol, Marjon
• Experimental Methods and Behavioral Insights in Health Economics: Estimating Risk and Time Preferences in Health (RePEc:eme:ceazzz:s0573-855520180000294001)
  by Matteo M. Galizzi & Glenn W. Harrison & Marisa Miraldo
• R&D Success in Pharmaceutical Markets: A Duration Model Approach (RePEc:eme:ceazzz:s0573-855520180000294010)
  by Eliana Barrenho & Marisa Miraldo
• Inequities in cancer drug development in terms of unmet medical need (RePEc:hal:ipppap:halshs-03672739)
  by Eliana Barrenho & Réka Halmai & Marisa Miraldo & Iván Tzintzun & Setti Raïs Ali & Léa Toulemon & Jean-Claude Dupont & Lise Rochaix
• Inequities in cancer drug development in terms of unmet medical need (RePEc:hal:journl:halshs-03672739)
  by Eliana Barrenho & Réka Halmai & Marisa Miraldo & Iván Tzintzun & Setti Raïs Ali & Léa Toulemon & Jean-Claude Dupont & Lise Rochaix
• Inequities in cancer drug development in terms of unmet medical need (RePEc:hal:pseptp:halshs-03672739)
  by Eliana Barrenho & Réka Halmai & Marisa Miraldo & Iván Tzintzun & Setti Raïs Ali & Léa Toulemon & Jean-Claude Dupont & Lise Rochaix
• The determinants of attrition in drug development: a duration analysis (RePEc:imp:wpaper:12204)
  by Barrenho, E & Smith, PC & Miraldo, M
• Doctor-patient differences in risk preferences, and their links to decision-making: a field experiment (RePEc:imp:wpaper:12578)
  by Miraldo, M & Galizzi, M & Stavropoulou, C
• Price regulation of pluralistic markets subject to provider collusion (RePEc:imp:wpaper:1454)
  by Longo, R & Miraldo, M & Street, A
• Collusion in regulated pluralistic markets (RePEc:imp:wpaper:15402)
  by Miraldo, M & Crea, G & Longo, R & Street, A
• In sickness but not in wealth: Field evidence on patients’ risk preferences in the financial and health domain (RePEc:imp:wpaper:31053)
  by Miraldo, M & Galizzi, M & Stavropoulou, C
• Economies of scale and scope in the English hospital sector (RePEc:imp:wpaper:4202)
  by Miraldo, M
• Are you what you eat? Experimental evidence on risk preferences and health habits (RePEc:imp:wpaper:9792)
  by Miraldo, M & Galizzi, MM
• Optimal Hospital Care Scheduling During the SARS-CoV-2 Pandemic (RePEc:inm:ormnsc:v:69:y:2023:i:10:p:5923-5947)
  by Josh C. D’Aeth & Shubhechyya Ghosal & Fiona Grimm & David Haw & Esma Koca & Krystal Lau & Huikang Liu & Stefano Moret & Dheeya Rizmie & Peter C. Smith & Giovanni Forchini & Marisa Miraldo & Wolfram Wi
• Impacts of introducing and lifting nonpharmaceutical interventions on COVID-19 daily growth rate and compliance in the United States (RePEc:nas:journl:v:118:y:2021:p:e2021359118)
  by Surya Singh & Mujaheed Shaikh & Katharina Hauck & Marisa Miraldo
• Projected impact of the Portuguese sugar-sweetened beverage tax on obesity incidence across different age groups: A modelling study (RePEc:plo:pmed00:1003036)
  by Francisco Goiana-da-Silva & Milton Severo & David Cruz e Silva & Maria João Gregório & Luke N Allen & Magdalena Muc & Alexandre Morais Nunes & Duarte Torres & Marisa Miraldo & Hutan Ashrafian & Ana Ri
• Waiting time at health facilities and social class: Evidence from the Indian caste system (RePEc:plo:pone00:0205641)
  by Mujaheed Shaikh & Marisa Miraldo & Anna-Theresa Renner
• Innovation Diffusion and Physician Networks: Keyhole Surgery for Cancer in the English NHS (RePEc:qld:uq2004:638)
  by Eliana Barrenho & Eric Gautier & Marisa Miraldo & Carol Propper & Christiern Rose
• Identification of Peer Effects using Panel Data (RePEc:qld:uq2004:639)
  by Marisa Miraldo & Carol Propper & Christiern Rose
• In Sickness but Not in Wealth (RePEc:sae:medema:v:36:y:2016:i:4:p:503-517)
  by Matteo M. Galizzi & Marisa Miraldo & Charitini Stavropoulou
• Distribution of health-related social surplus in pharmaceuticals: an estimation of consumer and producer surplus in the management of high blood lipids and COPD (RePEc:spr:eujhec:v:15:y:2014:i:4:p:439-445)
  by Rodrigo Camejo & Clare McGrath & Marisa Miraldo & Frans Rutten
• Erratum to: Distribution of health-related social surplus in pharmaceuticals: an estimation of consumer and producer surplus in the management of high blood lipids and COPD (RePEc:spr:eujhec:v:15:y:2014:i:4:p:447-447)
  by Rodrigo Refoios Camejo & Clare McGrath & Marisa Miraldo & Frans Rutten
• The impact of hospital price and quality transparency tools on healthcare spending: a systematic review (RePEc:spr:hecrev:v:12:y:2022:i:1:d:10.1186_s13561-022-00409-4)
  by Jinyang Chen & Marisa Miraldo
• Effects of Reference Pricing in Pharmaceutical Markets (RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33)
  by Matteo Galizzi & Simone Ghislandi & Marisa Miraldo
• The Determinants of Cost-Effectiveness Potential: An Historical Perspective on Lipid-Lowering Therapies (RePEc:spr:pharme:v:31:y:2013:i:5:p:445-454)
  by Rodrigo Refoios Camejo & Clare McGrath & Marisa Miraldo & Frans Rutten
• Are You What You Eat? Experimental Evidence on Health Habits and Risk Preferences (RePEc:ubs:wpaper:1003)
  by Matteo M. Galizzi & Marisa Miraldo
• Giving greater financial independence to hospitals—does it make a difference? The case of English NHS Trusts (RePEc:wly:hlthec:v:17:y:2008:i:6:p:751-775)
  by Giorgia Marini & Marisa Miraldo & Rowena Jacobs & Maria Goddard
• Does global drug innovation correspond to burden of disease? The neglected diseases in developed and developing countries (RePEc:wly:hlthec:v:28:y:2019:i:1:p:123-143)
  by Eliana Barrenho & Marisa Miraldo & Peter C. Smith
• Excess influenza hospital admissions and costs due to the 2009 H1N1 pandemic in England (RePEc:wly:hlthec:v:28:y:2019:i:2:p:175-188)
  by Krystal Lau & Katharina Hauck & Marisa Miraldo
• Bandwagoning, free‐riding and heterogeneity in influenza vaccine decisions: An online experiment (RePEc:wly:hlthec:v:31:y:2022:i:4:p:614-646)
  by Matteo M. Galizzi & Krystal W. Lau & Marisa Miraldo & Katharina Hauck
• The costs of new organisational and financial freedom: The case of English NHS trusts (RePEc:yor:hectdg:09/26)
  by Marini G & Miraldo M
• Peer and network effects in medical innovation: the case of laparoscopic surgery in the English NHS (RePEc:yor:hectdg:19/10)
  by Barrenho, E.; & Miraldo, M.; & Propper, C; & Rose, C.;